Buy? Sell? Hold. Wait. Investors should just wait for Valeant (VRX) to file first quarter 2016 results. If company shows significant improvement in cash flow (FCF positive), BUY. If company affirms no need in selling assets or divisions, BUY. If anything crops up. Sell, Avoid. Meanwhile, RLYP is a buy at $12, Sell at $20. MNKD is headed to $0.50. ARIA will keep going up. GILD and CELG will rebound. MDVN will be acquired, probably by Pfizer.